Deals & business · first seen 44m ago, updated 44m ago

Nektar prevails in legal battle with Lilly over broken rezpeg partnership

1 outlet Eli Lilly

Nektar Therapeutics has been awarded $90 million in damages after a jury sided with the biotech, which had accused Big Pharma Eli Lilly of “botching” an analysis of their formerly partnered autoimmune drug.

Summary from BioSpace - All News.

Coverage 1 article · 1 outlet

BioSpace - All News 44m ago
Nektar prevails in legal battle with Lilly over broken rezpeg partnership